ABI Says Verdict, R&D Increase Curtailed Net Income Despite Strong Q1 Revenue Growth | GenomeWeb

NEW YORK, Oct. 24 - Applied Biosystems today reported that strong demand for its mass spectrometers helped drive overall growth in revenue for its fiscal first quarter. But a $16.4 million charge related to a $13.3 million jury verdict contributed to a dip in net earnings during the quarter.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.